Cargando…
The small-molecule protein ligand interface stabiliser E7820 induces differential cell line specific responses of integrin α2 expression
BACKGROUND: The mechanism of small-molecule stabilised protein-protein interactions is of growing interest in the pharmacological discovery process. A plethora of different substances including the aromatic sulphonamide E7820 have been identified to act by such a mechanism. The process of E7820 indu...
Autores principales: | Hülskamp, Michael David, Kronenberg, Daniel, Stange, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132423/ https://www.ncbi.nlm.nih.gov/pubmed/34006252 http://dx.doi.org/10.1186/s12885-021-08301-w |
Ejemplares similares
-
Evaluation of α(2)-Integrin Expression as a Biomarker for Tumor Growth Inhibition for the Investigational Integrin Inhibitor E7820 in Preclinical and Clinical Studies
por: Keizer, Ron J., et al.
Publicado: (2011) -
Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15
por: Faust, Tyler, et al.
Publicado: (2019) -
Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor–tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models
por: Ito, Ken, et al.
Publicado: (2014) -
Small molecules that inhibit TNF signalling by stabilising an asymmetric form of the trimer
por: O’Connell, James, et al.
Publicado: (2019) -
Dialumenes – aryl vs. silyl stabilisation for small molecule activation and catalysis
por: Weetman, Catherine, et al.
Publicado: (2020)